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OBJECTIVE—Fatty acid–induced mitochondrial uncoupling
and oxidative stress have been proposed to reduce cardiac
efﬁciency and contribute to cardiac dysfunction in type 2 diabe-
tes. We hypothesized that mitochondrial uncoupling may also
contribute to reduced cardiac efﬁciency and contractile dysfunc-
tion in the type 1 diabetic Akita mouse model (Akita).
RESEARCH DESIGN AND METHODS—Cardiac function and
substrate utilization were determined in isolated working hearts
and in vivo function by echocardiography. Mitochondrial func-
tion and coupling were determined in saponin-permeabilized
ﬁbers, and proton leak kinetics was determined in isolated
mitochondria. Hydrogen peroxide production and aconitase ac-
tivity were measured in isolated mitochondria, and total reactive
oxygen species (ROS) were measured in heart homogenates.
RESULTS—Resting cardiac function was normal in Akita mice,
and myocardial insulin sensitivity was preserved. Although Akita
hearts oxidized more fatty acids, myocardial O2 consumption
was not increased, and cardiac efﬁciency was not reduced.
ADP-stimulated mitochondrial oxygen consumption and ATP
synthesis were decreased, and mitochondria showed grossly
abnormal morphology in Akita. There was no evidence of oxida-
tive stress, and despite a twofold increase in uncoupling protein
3 (UCP3) content, ATP-to-O ratios and proton leak kinetics were
unchanged, even after perfusion of Akita hearts with 1 mmol/l
palmitate.
CONCLUSIONS—Insulin-deﬁcient Akita hearts do not exhibit
fatty acid–induced mitochondrial uncoupling, indicating impor-
tant differences in the basis for mitochondrial dysfunction be-
tween insulin-responsive type 1 versus insulin-resistant type 2
diabetic hearts. Increased UCP3 levels do not automatically
increase mitochondrial uncoupling in the heart, which supports
the hypothesis that fatty acid–induced mitochondrial uncoupling
as exists in type 2 diabetic hearts requires a concomitant
increase in ROS generation. Diabetes 57:2924–2932, 2008
C
ardiac efﬁciency is the ratio of cardiac work to
myocardial O2 consumption (Vo2). Impaired
cardiac efﬁciency has been proposed to be an
underlying mechanism leading to cardiac con-
tractile dysfunction in type 2 diabetes (1,2). In type 2
diabetic db/db and ob/ob mice, increased fatty acid utiliza-
tion and myocardial Vo2 are not accompanied by a pro-
portionate increase in contractile function, resulting in
reduced cardiac efﬁciency (3,4). We previously demon-
strated that fatty acid–induced mitochondrial uncoupling
occurs in the hearts of these mice and likely results from
activation of cardiac uncoupling proteins (5,6). Thus,
increased fatty acid utilization in type 2 diabetic hearts is
associated with mitochondrial uncoupling, which leads to
decreased ATP production. This prevents a proportionate
increase in cardiac work and results in reduced cardiac
efﬁciency (1). The presence of increased mitochondrial
reactive oxygen species (ROS) production in db/db mice
and the ability of ROS to activate uncoupling proteins also
suggested that fatty acid–induced mitochondrial uncou-
pling in these hearts required the presence of increased
ROS (6,7). Although fatty acid–induced uncoupling may
contribute to reduced cardiac efﬁciency in type 2 diabetic
models, it is not known whether mitochondrial uncoupling
also contributes to impaired cardiac efﬁciency and con-
tractile dysfunction in models of type 1 diabetes.
Most studies of type 1 diabetes in rodents have been
performed after induction of diabetes with streptozotocin.
In streptozotocin-induced diabetic mice, many cardiac
alterations are similar to type 2 diabetic hearts, such as
increased fatty acid oxidation, reduced glucose oxidation,
impaired mitochondrial respiration, oxidative stress, and
impaired contractile function (8–11). In addition, it was
reported that cardiac efﬁciency was reduced in streptozo-
tocin-injected animals, and expression of uncoupling pro-
tein 3 (UCP3) was increased (8,12). These similarities to
type 2 diabetic models prompted us to investigate in this
study whether mitochondrial uncoupling also contributes
to impaired cardiac efﬁciency and contractile dysfunction
in type 1 diabetic models. To date, measurements of
cardiac state 4 respiration rates and ADP-to-O ratios
performed in streptozotocin-injected animals have yielded
conﬂicting results, making it difﬁcult to make any conclu-
sions about the presence or absence of mitochondrial
uncoupling in this model of type 1 diabetes (8,13–15).
Potential extrapancreatic toxic effects are a disadvan-
tage of the streptozotocin model, in particular when
high-dose streptozotocin administration is used (16). In
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this model, and mitochondrial dysfunction may or may not
occur (17). To circumvent these concerns, genetic models
of type 1 diabetes are increasingly used, and the Animal
Models of Diabetic Complications Consortium (AMDCC)
has proposed the Akita diabetic mouse as a useful model
with which to study the chronic complications of type 1
diabetes (18). This mouse develops diabetes as a conse-
quence of a single base pair substitution in the Ins2 gene,
resulting in improper folding of proinsulin, which leads to
protein aggregate–induced endoplasmic reticulum stress
in pancreatic islets (19,20) and eventual -cell failure (19).
Akita mice are severely hyperglycemic by 5–6 weeks of
age and develop typical chronic complications of diabetes,
such as retinopathy, neuropathy, and nephropathy (21,22).
In this study, we hypothesized that mitochondrial un-
coupling may also contribute to reduced cardiac efﬁciency
and contractile dysfunction in type 1 diabetes. To test our
hypothesis, we measured cardiac contractile function,
energy substrate metabolism, and mitochondrial function
and coupling in the type 1 diabetic Akita mouse model
(Akita). The main ﬁnding of this study was that Akita
hearts are protected from fatty acid–induced mitochon-
drial uncoupling despite increased UCP3 expression. Our
data imply that mechanisms for mitochondrial dysfunction
differ importantly between insulin-deﬁcient type 1 and
insulin-resistant type 2 diabetic hearts.
RESEARCH DESIGN AND METHODS
Male Akita mice (C57BL/6) and C57BL/6 controls were obtained from The
Jackson Laboratories (Bar Harbor, ME) and housed at 22°C with free access
to water and food with a light cycle of 12 h light and 12 h dark. Animals were
studied in accordance with protocols approved by the Institutional Animal
Care and Use Committee of the University of Utah. All studies were performed
in random-fed animals.
Serum analyses. Free fatty acid concentrations, triacylglycerol levels, and
blood glucose levels were measured as previously described (4).
Echocardiography. Contractile function and left ventricular chamber dimen-
sions were measured as described previously (23).
Heart perfusions. Contractile function and substrate metabolism were
measured in isolated working hearts perfused with Krebs-Henseleit buffer
(KHB) containing 5 mmol/l glucose and 0.4 mmol/l palmitate in the presence
or absence of 1 nmol/l insulin as previously described (3). For some
mitochondrial respiration studies, hearts were perfused in the Langendorff
mode with KHB containing 11 mmol/l glucose and 1 mmol/l palmitate for 30
min (5). The effect of a calcium-induced increase in workload on contractility
was investigated in Langendorff-perfused hearts with KHB (5 mmol/l glucose
and 0.4 mmol/l palmitate) (5). Hearts were perfused for 40 min, and calcium
was raised from 2 to 4 mmol/l after 20 min.
Mitochondrial function. Saponin-permeabilized ﬁbers were prepared from
freshly excised or Langendorff-preperfused hearts as described previously (5).
Respiration and ATP synthesis were measured using 20 mol/l palmitoyl
carnitine, 10 mmol/l pyruvate, or 5 mmol/l glutamate as substrates, each
combined with 2 mmol/l malate. Respiration was measured in the presence of
substrate alone (V0), after addition of 1 mmol/l ADP (VADP), and after addition
of 1 g/ml F0F1-ATPase inhibitor oligomycin (VOligo).
Proton leak kinetics. Proton leak measurements were performed in hearts
that were preperfused for 20 min with 11 mmol/l glucose and 1 mmol/l
palmitate. Mitochondria were prepared from whole hearts by differential
centrifugation, and proton leak kinetics was measured in the presence of 20
mol/l palmitoyl carnitine as previously described (6,24).
Electron microscopy. Hearts were freshly excised and immediately washed
in ice-cold saline. Samples were collected from left ventricular myocardium
and processed as described previously (6). Mitochondrial volume density and
number were analyzed by stereology in a blinded fashion using the point-
counting method (6,25).
Hydrogen peroxide production. Mitochondrial hydrogen peroxide (H2O2)
generation was measured using succinate as a substrate as described previ-
ously (6). To block H2O2 production at complex I, 10 mol/l rotenone was
added to the reaction. Mitochondrial H2O2 production is widely accepted as a
measure of mitochondrial superoxide production.
Oxidative stress. Tissue ROS levels were measured by the conversion of
nonﬂuorescent 2,7 -dichloroﬂuorescein-diacetate (DCFDA) to the highly
ﬂuorescent 2,7 -dichloroﬂuorescein (DCF) in the presence of esterases and
ROS (26) (for details, see the supplementary methods available in an online
appendix at http://dx.doi.org/10.2337/db08-0079). Activity of mitochondrial
aconitase was measured in isolated mitochondria as described previously
(27).
RNA extraction and quantitative RT-PCR. Total RNA was extracted from
hearts with Trizol reagent (Invitrogen, Carlsbad, CA), puriﬁed with the
RNEasy kit (Qiagen, Valencia, CA), and reverse transcribed (6). Data were
normalized by expressing them relative to the levels of the invariant transcript
16S RNA. Primer sequences and accession numbers are presented in supple-
mentary Table 1.
Western blot analysis. Isolated mitochondria or whole-cell extracts were
prepared as described previously and resolved by SDS-PAGE (5,6). For
antibody conditions see supplementary methods in the online appendix.
Protein concentrations were determined using the Micro BCA Protein Assay
kit (Pierce, Rockford, IL), and equal protein loading was veriﬁed by Coomas-
sie staining.
Statistical analysis. Data are presented as means  SE. When comparing
two groups, signiﬁcance was determined using a Student’s t test. Effects of
calcium-induced increase in contractility were analyzed using a paired t test.
Analysis of working heart perfusions  insulin was performed using
one-way ANOVA. Signiﬁcance was assessed by Fisher’s protected least
signiﬁcant difference test. For all analyses, the Statview 5.0.1 software
package was used (SAS Institute, Cary, NC), and signiﬁcant difference was
accepted when P  0.05.
RESULTS
Serum metabolites and cardiac growth. Akita diabetic
mice develop type 1 diabetes as early as 5–6 weeks of age
and show normal survival until 6 months of age but then
show a dramatic decrease in survival with almost no
survivors by 12 months of age (19). To investigate the
long-term effects of type 1 diabetes on the heart, we chose
to investigate mice mainly at 24 weeks of age. Serum
glucose levels were markedly increased in Akita mice at 24
weeks of age (138  5 vs. 566  21 mg/dl; P  0.05).
Hyperglycemia was accompanied by increased serum fatty
acid levels (261  43 vs. 537  72 mol/l; P  0.05) and
increased serum triacylglycerol levels (0.98  0.11 vs.
2.40  0.54 mmol/l; P  0.05). In contrast to wild-type
mice, Akita mice showed no increase in body weights as
they aged (supplementary Table 2). Heart weights and
tibia lengths were measured at 10, 24, and 54 weeks of age
in the Akita mice (supplementary Table 2). Although
heart-to-tibia length ratios were not different at 10 weeks,
we observed reduced ratios at 24 and 54 weeks of age.
Heart weight–to–body weight ratios were not reduced,
indicating that the reduction in heart size parallels the
general catabolic state of diabetic Akita mice.
Cardiac function. Cardiac contractile function and cham-
ber dimensions were examined in Akita diabetic mice by
echocardiography at 20, 36, and 54 weeks of age. Frac-
tional shortening and ejection fraction were not different
at any age (Table 1), and there were no differences in
chamber dimensions in diabetic and nondiabetic mice
(supplementary Table 3). Cardiac output was increased at
20 weeks of age but was lower at 54 weeks of age in Akita
mice, which was likely due to a moderate but nonsigniﬁ-
cant reduction in heart rate. Because adaptations of the
neurohumoral system can mask the presence of contrac-
tile dysfunction in vivo, we investigated contractile func-
tion in isolated working hearts in the absence and
presence of insulin (Fig. 1A–C). In the absence of insulin,
left ventricular developed pressure was reduced in 24-
week-old Akita mice, and a trend toward increased cardiac
output in Akita hearts led to no differences in cardiac
power. Insulin had a positive inotropic effect in wild-type
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(bpm) were not signiﬁcantly changed from baseline by
insulin (basal vs. insulin: wild type, 263  8 vs. 281  8;
Akita, 290  5 vs. 310  9). To further evaluate myocardial
contractile reserve, Langendorff-perfused hearts were ex-
amined under normal and increased calcium concentra-
tions. Contractile parameters were similar in 15-week-old
wild-type and Akita mice under baseline conditions (2
mmol/l calcium). Changing perfusion conditions to 4
mmol/l calcium signiﬁcantly increased systolic pressure,
developed pressure, and rate pressure product in wild-
type and Akita mice by equivalent extents (supplementary
Table 4). Thus, despite persistent hyperglycemia, Akita
mice exhibited modest left ventricular dysfunction that
was evident mainly in insulin-perfused working hearts. In
contrast to ob/ob mice (5), short-term inotropic reserves
were maintained.
Substrate metabolism, insulin signaling, and cardiac
efﬁciency. Decreased cardiac efﬁciency is believed to be
an important contributor to the development of contrac-
tile dysfunction in type 2 diabetic models and has been
postulated to result from fatty acid–induced mitochon-
drial uncoupling (1). We therefore measured cardiac
substrate utilization and oxygen consumption in iso-
lated working hearts of 24-week-old Akita mice in the
absence and presence of insulin. Palmitate oxidation
rates were increased and glucose oxidation rates were
decreased in the presence or absence of 1 nmol/l insulin
in Akita hearts compared with the wild type (Fig. 1D and
E). Despite increased fatty acid oxidation, myocardial
Vo2 and cardiac efﬁciency were not different between
wild-type and Akita mice (Fig. 1G and H). Of interest,
metabolic insulin responsiveness was retained in Akita
hearts. Thus, insulin-suppressed palmitate oxidation
increased glycolysis and glucose oxidation in both wild-
type and Akita mice (Fig. 1D–F). Consistent with intact
metabolic insulin signaling, insulin-stimulated Akt phos-
phorylation on Ser
473 was maintained in hearts of 10- and
24-week-old mice (Fig. 2A and B). Thus, despite increased
fatty acid utilization, Akita hearts maintained normal insu-
lin sensitivity.
Mitochondrial oxygen consumption and respiratory
coupling. The absence of reduced cardiac efﬁciency was
unexpected and revealed an important difference between
FIG. 1. Substrate oxidation and contractile performance of Akita hearts. 24-week-old wild-type and Akita mouse hearts were perfused in the
isolated working mode without insulin (basal) or in the presence of 1 nmol/l insulin (n  4–5). A: Left ventricular–developed pressure (LVDevP).
B: Cardiac output. C: Cardiac power. D: Palmitate oxidation. E: Glucose oxidation. F: Glycolysis. G: Oxygen consumption. H: Cardiac efﬁciency.
*P < 0.05 vs. wild type, P < 0.05 vs. without insulin.
TABLE 1
Echocardiographic evaluation of contractile function in wild-type and Akita mice at 20, 36, and 54 weeks of age
n
Fractional
shortening (%)
Ejection
fraction (%)
Heart rate
(bpm)
Stroke volume
(l/g body wt)
Cardiac output
(l  min
1 
g
1 body wt)
Wild type (20 weeks) 9 38.6  2.4 76  3 415  12 1.13  0.03 467  14
Akita (20 weeks) 7 38.7  2.4 76  3 472  31 1.12  0.07 527  15*
Wild type (36 weeks) 6 39.6  1.2 78  1 470  41 0.97  0.04 456  25
Akita (36 weeks) 5 39.7  2.7 78  3 421  29 1.13  0.04* 476  33
Wild type (54 weeks) 6 24.6  1.9 57  3 523  29 1.00  0.10 524  28
Akita (54 weeks) 6 27.6  1.9 62  3 448  28 0.95  0.04 426  28*
Data are means  SE unless otherwise indicated. *P  0.05 vs. wild type.
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models. Because mitochondrial uncoupling may underlie
impaired cardiac efﬁciency in type 2 diabetic hearts (1,5,6),
we hypothesized that mitochondrial coupling would be
normal in Akita hearts. Mitochondrial function was ini-
tially evaluated in ﬁbers that were prepared from freshly
isolated mouse hearts. In hearts from 24-week-old mice,
maximal ADP-stimulated mitochondrial oxygen consump-
tion (VADP) and ATP synthesis were unchanged using
palmitoyl carnitine as a substrate (Fig. 3A and E), but VADP
and ATP synthesis were signiﬁcantly reduced in Akita
mice using pyruvate (Fig. 3B and F) or glutamate (Fig. 3C
and G) as substrates. Although a respiratory defect was
evident, there was no evidence for mitochondrial uncou-
pling. Rates of oligomycin-insensitive respirations (Voligo)
and ATP-to-O ratios were unchanged with any substrate,
indicating intact coupling of ATP synthesis to oxygen
consumption. In 10-week-old mice, similar reductions in
FIG. 2. Intact insulin signaling in Akita hearts. Representative Western blot images showing cardiac protein levels of phosphorylated Akt (p-Akt)
on Ser
473 and total levels of Akt (t-Akt) and densitometric quantiﬁcation of the ratio of p-Akt to t-Akt (p-Akt/t-Akt) after isolated working heart
perfusions in the absence (basal) or presence of 1 nmol/l insulin at the age of 10 weeks (A) and 24 weeks (B). *P < 0.05 vs. basal, P < 0.05 vs.
wild-type (WT).
FIG. 3. Preserved mitochondrial coupling and impaired mitochondrial oxidative capacity in Akita hearts. Mitochondrial respiratory rates (A–C)
and ATP synthesis and ATP-to-O ratios (E–G) of saponin-permeabilized cardiac ﬁbers from 24-week-old wild-type (WT) and Akita mice using
palmitoyl carnitine (A and E), pyruvate (B and F), or glutamate (C and G) as a substrate (n  6). Similar data were also obtained in 10-week-old
mice after incubation with glutamate (D and H), n  6. *P < 0.05 vs. wild type.
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(Fig. 3D). ATP synthesis rates were proportionately re-
duced; thus, ATP-to-O ratios were not different (Fig. 3H).
We previously reported that mitochondrial uncoupling
became evident in ob/ob and db/db mouse hearts after
hearts were perfused with increased concentrations of
fatty acids (5,6). Thus, palmitoyl carnitine respirations
were determined in permeabilized ﬁbers from hearts of
10-week-old Akita and control mice after perfusion with 11
mmol/l glucose and 1 mmol/l palmitate (Fig. 4A and B).
Under these conditions, we observed no differences in
VADP,V oligo, ATP production rates, or ATP-to-O ratios.
Finally, to provide more deﬁnitive evidence for the ab-
sence of mitochondrial uncoupling in Akita hearts, we
isolated mitochondria from hearts of 24-week-old Akita
mice after perfusion of hearts with 11 mmol/l glucose and
1 mmol/l palmitate and measured proton leak kinetics
(Fig. 4C). Proton leak kinetics curves were entirely over-
lapping between mitochondria from Akita mice and non-
diabetic controls, indicating the absence of mitochondrial
uncoupling.
Expression of mitochondrial genes and mitochon-
drial morphology. To understand the molecular basis for
impaired mitochondrial respiratory capacity with gluta-
mate and pyruvate, we investigated gene expression in
Akita and wild-type hearts at 24 weeks of age (Fig. 5A).
Expression of genes encoding for subunits of the electron
transport chain was reduced for four of ﬁve genes exam-
ined in Akita mice. In contrast, two forms of peroxisome
proliferator–activated  coactivator-1 (PGC-1 and PGC-
1) and their downstream mediators (nuclear respiratory
factor 1 [NRF1], mitochondrial transcription factor A
[TFAm], and estogen-related receptor- [ERR]) were not
differentially expressed. Genes encoding for peroxisome
proliferator–activated receptor  (PPAR) and for en-
zymes and transporters of fatty acid utilization did not
show a uniform trend toward increased expression except
for malonyl CoA decarboxylase. Expression of GLUT1 and
GLUT4 was reduced, and expression of pyruvate dehydro-
genase kinase 4 (PDK4) was increased in Akita, consistent
with impaired glucose oxidation in Akita. Interestingly,
expression of UCP2 and UCP3 was signiﬁcantly increased
in Akita, and these changes were accompanied by in-
creased expression of mitochondrial thioesterase 1
(MTE1). Consistent with increased mRNA levels, there
was a twofold increase in UCP3 protein content (Fig. 5B).
This observation is of particular interest because we
detected no evidence of mitochondrial uncoupling in
mitochondria from Akita mice.
Electron microscopy revealed markedly reduced cristae
density in Akita but not in wild-type mice (Fig. 6A). Of the
images evaluated, 75% showed lipid droplets in Akita mice,
but no lipid droplets were observed in wild-type mice
(arrows in Fig. 6A). Although mitochondrial volume den-
sity was increased in Akita mice, mitochondrial number
was unchanged between the groups (Fig. 6B and C).
No evidence for oxidative stress or increased ROS in
Akita hearts. Thus far, we have shown that Akita mito-
chondria reveal defects in oxygen consumption in the
absence of mitochondrial uncoupling (despite increased
UCP3 content). We previously demonstrated that in type 2
diabetic db/db mice, fatty acid–induced mitochondrial
uncoupling is mediated by activation of UCPs in the
presence of increased ROS production and evidence of
oxidative stress. These results suggested that increased
ROS is required for activation of UCPs in diabetic hearts
(6). We therefore hypothesized that the absence of mito-
chondrial uncoupling in Akita hearts despite increased
UCP3 content was due to reduced ROS in Akita hearts.
Consistent with this hypothesis, there was no increase in
mitochondrial H2O2 production. Akita mice showed a
38–46% decrease in mitochondrial H2O2 generation com-
pared with wild-type mice at 10 or 24 weeks of age (Fig. 7A
and D). Addition of the complex I inhibitor rotenone
FIG. 4. Fatty acid perfusion does not induce mitochondrial uncoupling.
Mitochondrial respiratory rates (A) and ATP synthesis and ATP-to-O ratios
(B) of saponin-permeabilized cardiac ﬁbers generated from 24-week-old
wild-type (WT) and Akita mouse hearts that were perfused with KHB
containing 11 mmol/l glucose and 1 mmol/l palmitate. Palmitoyl carnitine was
used as respiratory substrate (n  6). C: Proton leak kinetics of mitochon-
dria isolated from 24-week-old wild-type and Akita mouse hearts preperfused
with KHB containing 11 mmol/l glucose and 1 mmol/l palmitate. Palmitoyl
carnitine was used as respiratory substrate (n  6).
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mitochondrial ROS production mainly arises from com-
plex I in wild-type and Akita mice. Mitochondrial aconi-
tase activity was not decreased in Akita mice at both ages
(Fig. 7B and E), and oxidation of 2-7-dichloﬂuoroscein
diacetate (DCFDA), a measure of tissue ROS levels, was
unaltered in 24-week-old hearts (Fig. 7C). In addition,
there was no induction of antioxidant defense pathways.
Transcript levels of glutathione peroxidase 1, mitochon-
drial manganese superoxide dismutase (SOD2), and per-
oxiredoxin 3 (PRDX3) were either unchanged or even
reduced in Akita (Fig. 5A). Similarly, protein levels of
SOD2 and PRDX3 were unchanged between the groups
(Fig. 7F and G).
DISCUSSION
Reduced cardiac efﬁciency is a well-described character-
istic of type 2 diabetic hearts in animal models and
humans (3,28). In this study, we addressed the following
question: Do impaired cardiac efﬁciency and fatty acid–
induced mitochondrial uncoupling contribute to cardiac
contractile dysfunction in type 1 diabetic Akita mice?
Similar to type 2 diabetic hearts, substrate metabolism
shifts toward increased fatty acid metabolism, and mito-
chondrial oxidative capacity is impaired. However, in
contrast to type 2 diabetic mouse models, Akita mice show
relatively preserved contractile function under ambient
conditions, no impairment in cardiac efﬁciency, and no
evidence of mitochondrial uncoupling (normal Voligo, ATP-
to-O ratios, and proton leak). Perfusion of hearts with high
fatty acid concentrations was not sufﬁcient to induce
mitochondrial uncoupling despite the presence of in-
creased UCP3 levels. Moreover, the absence of oxidative
stress distinguishes the Akita mouse from type 2 diabetic
models. Thus, the molecular mechanisms for mitochon-
drial dysfunction importantly differ between insulin-deﬁ-
cient type 1 and insulin-resistant type 2 diabetic mice. We
also show that increased UCP3 does not invariably lead to
increased mitochondrial uncoupling in the heart, support-
ing the hypothesis that fatty acid–induced mitochondrial
uncoupling in diabetic hearts may require a concomitant
increase in ROS generation.
The absence of mitochondrial uncoupling in Akita
hearts was associated with the absence of oxidative stress.
Mitochondrial superoxide production, measured as H2O2
generation, was actually decreased, and the activity of
mitochondrial aconitase and oxidation of DCFDA, which
are independent measures of oxidative damage, were
unaltered in Akita hearts. The association of mitochon-
drial uncoupling with increased ROS and lipid peroxide
generation in type 2 diabetic db/db hearts (6) and the lack
of uncoupling and the absence of oxidative stress in type
1 diabetic Akita hearts suggest a causal interdependence
of ROS production and mitochondrial uncoupling in dia-
betic hearts. Superoxide increases proton conductance by
UCP3 in isolated rat skeletal muscle mitochondria, and
lipid peroxidation products, such as hydroxynonenal, in-
crease proton leak in isolated mitochondria from multiple
tissues, including the heart, via UCPs and adenine nucle-
otide translocator (7,24). Although fatty acids appear to be
required for proton transport of UCP2 and UCP3 when
reconstituted in liposomes, Echtay et al. (24) showed that
FIG. 5. Reduced OXPHOS expression and increased UCP expression. A: Myocardial gene expression in 24-week-old wild-type (WT) and Akita mice
normalized to 16S RNA transcript levels (n  8). Values represent fold change in mRNA transcript levels relative to wild type, which was assigned
as one (dashed line). B: Representative Western blot images and densitometric quantiﬁcation of UCP3 protein levels in isolated mitochondria
from 24-week-old wild-type and Akita mice (n  4). Coomassie blue staining was used as a loading control. *P < 0.05 vs. wild type.
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require the presence of fatty acids (29). Thus, it appears
that for fatty acid–induced mitochondrial uncoupling, as
observed to occur in type 2 diabetic hearts, an increase in
ROS may be required in addition to increased fatty acid
availability and utilization.
The absence of oxidative stress or of any increase in
ROS or H2O2 production in Akita hearts was unexpected.
Inhibition of mitochondrial H2O2 production in the pres-
ence of rotenone suggested that complex I accounted for
most of the ROS production in Akita and control hearts.
This contrasts with similar studies in mitochondria iso-
lated from db/db hearts in which additional mitochondrial
complexes (likely complex III) also contributed to ROS
generation (6). The reduction in ROS generation in Akita
mice suggested that there might be a defect at the level of
mitochondrial complex I. This was also supported by the
observation that mitochondrial respirations in the pres-
ence of glutamate and pyruvate, which are complex I
substrates, were also reduced, whereas this was not the
case with palmitoyl carnitine that delivers reducing equiv-
alents to complex I and complex II. Thus, a simple
increase in substrate ﬂux might not be sufﬁcient to in-
crease mitochondrial ROS generation in diabetic hearts in
the absence of speciﬁc alterations in mitochondrial com-
plex activities that amplify ROS generation.
Oxidative stress has been proposed to contribute to
mitochondrial dysfunction in the hearts of type 1 diabetes
mouse models (30,31). In the present study, we demon-
strated impaired mitochondrial function and perturbed
mitochondrial morphology in the absence of any evidence
of oxidative stress. Interestingly, impaired mitochondrial
morphology in the type 1 diabetic OVE26 mouse can be
normalized by overexpression of manganese superoxide
dismutase (MnSOD) or catalase in the heart, but MnSOD-
deﬁcient mice die from early dilated cardiomyopathy and
have normal cardiac mitochondrial morphology (30–32).
In other transgenic models, knockout of the mitochondrial
transcription factor A leads to reduced mitochondrial DNA
replication and transcription and enlarged mitochondria
with abnormal cristae morphology, and combined deletion
of the cardiac insulin and IGF1 receptor results in im-
paired oxidative phosphorylation (OXPHOS) gene tran-
scription and decreased mitochondria that appeared to be
less dense in electron micrographs (33–35). Thus, in some
contexts, changes in the content of electron transport
chain subunits can be associated with changes in mito-
chondrial morphology. Because insulin is a positive regu-
lator of OXPHOS gene expression and because OXPHOS
gene expression is decreased in the Akita mouse heart,
insulin deﬁciency as opposed to oxidative stress might be
an important contributor to mitochondrial dysfunction
and altered morphology in the Akita mouse model (36,37).
Defective insulin signaling has been reported to reduce
expression levels of genes involved in -oxidation (23), yet
fatty acid oxidation genes were unchanged or increased in
Akita mice. We believe that this reﬂects the impact of
PPAR activation in the face of increased fatty acid
availability.
An important observation in the present study is that
increased content of UCP3 in the heart should not be
taken to indicate increased mitochondrial uncoupling. We
previously reported that increased mitochondrial uncou-
pling activity can occur in the absence of any changes in
UCP3 content in hearts from ob/ob and db/db mice (5,6). It
is important to discuss what might drive UCP3 levels in
Akita mouse hearts. Besides detoxiﬁcation of ROS, UCP3
has been postulated to play a role in the regulation of fatty
acid metabolism. Conditions associated with increased
fatty acid availability, such as fasting, high-fat feeding, and
diabetes, result in increased UCP3 expression, likely due
to increased PPAR signaling (12,38–40). In general, mus-
cle UCP3 protein content is negatively related to fatty acid
oxidative capacity, and induction of UCP3 is most pro-
nounced in glycolytic muscle upon fasting and high-fat
feeding (41,42). Thus, increased UCP3 expression may
reﬂect an adaptive response to fatty acid overload (43).
Based on the fatty acid cycling model, it has been pro-
posed that export of fatty acid anions from the matrix
into the intermembrane space via UCPs may help to
lower intramitochondrial fatty acid levels if increased
fatty acid availability exceeds mitochondrial oxidative
FIG. 6. Altered mitochondrial morphology in Akita hearts. Represen-
tative longitudinal electron microscopy images of left ventricular wall
of 24-week-old wild-type (WT) and Akita mice (A), stereological
quantiﬁcation of mitochondrial volume density (B), and mitochondrial
number (C)( n  4). Magniﬁcations (10,000 and 40,000) are shown
on each image, and black arrows on the images indicate lipid droplets.
*P < 0.05 vs. wild type.
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drial fatty acids into harmful lipid peroxides could be
prevented. Expression of MTE1 often parallels that of
UCP3, and this was also the case in the present study.
MTE1 catalyzes conversion of acyl-CoAs back to fatty
acid anions, which can then be translocated out of the
matrix by UCPs (13,29). In the cytosol, they may be
reesteriﬁed and oxidized in the mitochondria, stored as
triglycerides, or used for other pathways. Nonesteriﬁed
fatty acids can be generated within mitochondria and
exported from the matrix, and these events are mark-
edly increased in cardiac mitochondria from streptozo-
tocin-induced type 1 diabetic rats (13). Despite
increased basal fatty acid oxidation, Akita mice also
revealed increased lipid droplets; thus, it is tempting to
speculate that fatty acyl-CoAs would be converted to
fatty acid anions by increased MTE1 activity, exported
by UCP3, reesteriﬁed, and stored as triglycerides. Thus,
UCPs would contribute to match fatty acid availability
with oxidation to prevent intramitochondrial lipotoxic
effects.
A number of important differences between Akita mice
and previously evaluated models of type 2 diabetes were
observed (3–6,8). First, there was a relative preservation
of cardiac function and preserved inotropic responses to a
calcium-induced increase in workload. This likely reﬂects
the more profound mitochondrial dysfunction in the type 2
models and a greater degree of mitochondrial uncoupling.
Preliminary studies do suggest, though, that cardiac dys-
function may develop in Akita mice after a longer-term
hemodynamic challenge, such as after isoproterenol infu-
sion (supplementary results and supplementary Table 5),
but the mechanisms for this remains to be elucidated.
Second, insulin sensitivity was preserved in Akita hearts in
contrast to the insulin resistance reported in models of
type 2 diabetes (2,3). Although insulin levels in diabetic
Akita are 40% of insulin levels in nondiabetic controls (19),
these ambient insulin concentrations might be sufﬁcient to
maintain mitochondrial function to a greater extent than
models in which insulin signaling is severely impaired.
Finally, myocardial Vo2 was not increased despite in-
creased oxidation rates of exogenous palmitate. Although
this may partly reﬂect the absence of mitochondrial un-
coupling, it is also possible that reduced oxidation of
glucose and endogenous triglycerides coupled with mito-
chondrial dysfunction reduced myocardial Vo2 in intact
perfused hearts.
In conclusion, despite a signiﬁcant increase in UCP3
content, insulin-deﬁcient Akita hearts do not develop fatty
acid–induced mitochondrial uncoupling, suggesting that
underlying mechanisms for mitochondrial dysfunction
may importantly differ between insulin-responsive type 1
versus insulin-resistant type 2 diabetic hearts. Increased
UCP3 levels do not invariably lead to increased mitochon-
drial uncoupling in the heart, thereby supporting the
hypothesis that fatty acid–induced mitochondrial uncou-
pling in diabetic hearts requires a concomitant increase in
ROS or lipid peroxide generation.
ACKNOWLEDGMENTS
H.B. has received a postdoctoral fellowship grant from the
German Research Foundation. S.B. has received postdoc-
toral fellowships from the Juvenile Diabetes Research
Foundation and the American Heart Association (AHA).
V.G.Z. has received a postdoctoral fellowship from the
AHA Western Afﬁliates. S.E.L. has received a VA Merit
Award. E.D.A. is an established investigator of the AHA.
This study was supported by National Institutes of Health
Grants UO1-HL-70525, UO1-HL-087947 (AMDCC), and
RO1-HL-070070.
REFERENCES
1. Boudina S, Abel ED: Mitochondrial uncoupling: a key contributor to
reduced cardiac efﬁciency in diabetes. Physiology 21:250–258, 2006
2. Bugger H, Abel ED: Molecular mechanisms for myocardial mitochondrial
dysfunction in the metabolic syndrome. Clin Sci 114:195–210, 2008
FIG. 7. Oxidative stress is absent in Akita hearts. H2O2 production in isolated mitochondria of wild-type (WT) and Akita mice at 24 weeks (A)
and 10 weeks (D) of age (n  4). Mitochondrial aconitase activity of wild-type and Akita mice at 24 weeks (B) and 10 weeks (E) of age (n  4).
C: Oxidation of DCFDA measured in cardiac whole-tissue extracts from 24-week-old wild-type and Akita mice (n  5). Representative Western
blot images and densitometric quantiﬁcation of MnSOD (F) and PRDX3 (G) in isolated mitochondria of 24-week-old wild-type and Akita mice
(n  4). Coomassie blue staining was used as a loading control. *P < 0.05 vs. wild type.
H. BUGGER AND ASSOCIATES
DIABETES, VOL. 57, NOVEMBER 2008 29313. Mazumder PK, O’Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC,
Boudina S, Abel ED: Impaired cardiac efﬁciency and increased fatty acid
oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53:2366–2374,
2004
4. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ,
Cooksey RC, Litwin SE, Abel ED: Reduced cardiac efﬁciency and altered
substrate metabolism precedes the onset of hyperglycemia and contractile
dysfunction in two mouse models of insulin resistance and obesity.
Endocrinology 146:5341–5349, 2005
5. Boudina S, Sena S, O’Neill BT, Tathireddy P, Young ME, Abel ED: Reduced
mitochondrial oxidative capacity and increased mitochondrial uncoupling
impair myocardial energetics in obesity. Circulation 112:2686–2695, 2005
6. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson
JI, Bugger H, Zaha VG, Abel ED: Mitochondrial energetics in the heart in
obesity-related diabetes: direct evidence for increased uncoupled respira-
tion and activation of uncoupling proteins. Diabetes 56:2457–2466, 2007
7. Echtay KS, Roussel D, St-Pierre J, Jekabsons MB, Cadenas S, Stuart JA,
Harper JA, Roebuck SJ, Morrison A, Pickering S, Clapham JC, Brand MD:
Superoxide activates mitochondrial uncoupling proteins. Nature 415:96–
99, 2002
8. How OJ, Aasum E, Severson DL, Chan WY, Essop MF, Larsen TS:
Increased myocardial oxygen consumption reduces cardiac efﬁciency in
diabetic mice. Diabetes 55:466–473, 2006
9. Flarsheim CE, Grupp IL, Matlib MA: Mitochondrial dysfunction accompa-
nies diastolic dysfunction in diabetic rat heart. Am J Physiol 271:H192–
H202, 1996
10. Tahiliani AG, Lopaschuk GD, McNeill JH: Effect of insulin treatment on
long-term diabetes-induced alteration of myocardial function. Gen Phar-
macol 15:545–547, 1984
11. Turko IV, Li L, Aulak KS, Stuehr DJ, Chang JY, Murad F: Protein tyrosine
nitration in the mitochondria from diabetic mouse heart: implications to
dysfunctional mitochondria in diabetes. J Biol Chem 278:33972–33977,
2003
12. Murray AJ, Panagia M, Hauton D, Gibbons GF, Clarke K: Plasma free fatty
acids and peroxisome proliferator-activated receptor  in the control of
myocardial uncoupling protein levels. Diabetes 54:3496–3502, 2005
13. Gerber LK, Aronow BJ, Matlib MA: Activation of a novel long-chain free
fatty acid generation and export system in mitochondria of diabetic rat
hearts. Am J Physiol Cell Physiol 291:C1198–C1207, 2006
14. Lashin O, Romani A: Mitochondria respiration and susceptibility to isch-
emia-reperfusion injury in diabetic hearts. Arch Biochem Biophys 420:
298–304, 2003
15. King KL, Young ME, Kerner J, Huang H, O’Shea KM, Alexson SE, Hoppel
CL, Stanley WC: Diabetes or peroxisome proliferator-activated receptor
alpha agonist increases mitochondrial thioesterase I activity in heart. J
Lipid Res 48:1511–1517, 2007
16. Bolzan AD, Bianchi MS: Genotoxicity of streptozotocin. Mutat Res 512:
121–134, 2002
17. Lashin O, Romani A: Hyperglycemia does not alter state 3 respiration in
cardiac mitochondria from type-I diabetic rats. Mol Cell Biochem 267:31–
37, 2004
18. Hsueh W, Abel ED, Breslow JL, Maeda N, Davis RC, Fisher EA, Dansky H,
McClain DA, McIndoe R, Wassef MK, Rabadan-Diehl C, Goldberg IJ:
Recipes for creating animal models of diabetic cardiovascular disease.
Circ Res 100:1415–1427, 2007
19. Yoshioka M, Kayo T, Ikeda T, Koizumi A: A novel locus, Mody4, distal to
D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese
C57BL/6 (Akita) mutant mice. Diabetes 46:887–894, 1997
20. Ron D: Proteotoxicity in the endoplasmic reticulum: lessons from the
Akita diabetic mouse. J Clin Invest 109:443–445, 2002
21. Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison
SW, Gardner TW, Bronson SK: The Ins2Akita mouse as a model of early
retinal complications in diabetes. Invest Ophthalmol Vis Sci 46:2210–2218,
2005
22. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM: Impact of
genetic background on nephropathy in diabetic mice. Am J Physiol Renal
Physiol 290:F214–F222, 2006
23. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D,
Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR,
Abel ED: Insulin signaling coordinately regulates cardiac size, metabolism,
and contractile protein isoform expression. J Clin Invest 109:629–639, 2002
24. Echtay KS, Esteves TC, Pakay JL, Jekabsons MB, Lambert AJ, Portero-Otin
M, Pamplona R, Vidal-Puig AJ, Wang S, Roebuck SJ, Brand MD: A
signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial
uncoupling. EMBO J 22:4103–4110, 2003
25. Weibel E: Steriological principles for morphometry in electron micro-
scopic cytology. Int Rev Cytol 26:235–302, 1979
26. Kim HJ, Kim KW, Yu BP, Chung HY: The effect of age on cyclooxygenase-2
gene expression: NF-kappaB activation and IkappaBalpha degradation.
Free Radic Biol Med 28:683–692, 2000
27. Yan LJ, Levine RL, Sohal RS: Oxidative damage during aging targets
mitochondrial aconitase. Proc Natl Acad SciUSA94:11168–11172, 1997
28. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD,
Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ: Effect
of obesity and insulin resistance on myocardial substrate metabolism and
efﬁciency in young women. Circulation 109:2191–2196, 2004
29. Jaburek M, Varecha M, Gimeno RE, Dembski M, Jezek P, Zhang M, Burn P,
Tartaglia LA, Garlid KD: Transport function and regulation of mitochon-
drial uncoupling proteins 2 and 3. J Biol Chem 274:26003–26007, 1999
30. Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, Epstein PN:
Catalase protects cardiomyocyte function in models of type 1 and type 2
diabetes. Diabetes 53:1336–1343, 2004
31. Shen X, Zheng S, Metreveli NS, Epstein PN: Protection of cardiac mito-
chondria by overexpression of MnSOD reduces diabetic cardiomyopathy.
Diabetes 55:798–805, 2006
32. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ,
Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ: Dilated
cardiomyopathy and neonatal lethality in mutant mice lacking manganese
superoxide dismutase. Nat Genet 11:376–381, 1995
33. Wang J, Wilhelmsson H, Graff C, Li H, Oldfors A, Rustin P, Bruning JC,
Kahn CR, Clayton DA, Barsh GS, Thoren P, Larsson NG: Dilated cardio-
myopathy and atrioventricular conduction blocks induced by heart-spe-
ciﬁc inactivation of mitochondrial DNA gene expression. Nat Genet
21:133–137, 1999
34. Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, Lewandoski M,
Barsh GS, Clayton DA: Mitochondrial transcription factor A is necessary
for mtDNA maintenance and embryogenesis in mice. Nat Genet 18:231–
236, 1998
35. Laustsen PG, Russell SJ, Cui L, Entingh-Pearsall A, Holzenberger M, Liao
R, Kahn CR: Essential role of insulin and insulin-like growth factor 1
receptor signaling in cardiac development and function. Mol Cell Biol
27:1649–1664, 2007
36. Huang X, Eriksson KF, Vaag A, Lehtovirta M, Hansson M, Laurila E,
Kanninen T, Olesen BT, Kurucz I, Koranyi L, Groop L: Insulin-regulated
mitochondrial gene expression is associated with glucose ﬂux in human
skeletal muscle. Diabetes 48:1508–1514, 1999
37. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS: Effect of insulin
on human skeletal muscle mitochondrial ATP production, protein synthe-
sis, and mRNA transcripts. Proc Natl Acad SciUSA100:7996–8001, 2003
38. Tunstall RJ, Mehan KA, Hargreaves M, Spriet LL, Cameron-Smith D:
Fasting activates the gene expression of UCP3 independent of genes
necessary for lipid transport and oxidation in skeletal muscle. Biochem
Biophys Res Commun 294:301–308, 2002
39. Weigle DS, Selfridge LE, Schwartz MW, Seeley RJ, Cummings DE, Havel
PJ, Kuijper JL, BeltrandelRio H: Elevated free fatty acids induce uncou-
pling protein 3 expression in muscle: a potential explanation for the effect
of fasting. Diabetes 47:298–302, 1998
40. Young ME, Patil S, Ying J, Depre C, Ahuja HS, Shipley GL, Stepkowski SM,
Davies PJ, Taegtmeyer H: Uncoupling protein 3 transcription is regulated
by peroxisome proliferator-activated receptor (alpha) in the adult rodent
heart. FASEB J 15:833–845, 2001
41. Hoeks J, Hesselink MK, van Bilsen M, Schaart G, van der Vusse GJ, Saris
WH, Schrauwen P: Differential response of UCP3 to medium versus long
chain triacylglycerols: manifestation of a functional adaptation. FEBS Lett
555:631–637, 2003
42. Schrauwen P, Hoppeler H, Billeter R, Bakker AH, Pendergast DR: Fiber
type dependent upregulation of human skeletal muscle UCP2 and UCP3
mRNA expression by high-fat diet. Int J Obes Relat Metab Disord
25:449–456, 2001
43. Schrauwen P, Hoeks J, Hesselink MK: Putative function and physiological
relevance of the mitochondrial uncoupling protein-3: involvement in fatty
acid metabolism? Prog Lipid Res 45:17–41, 2006
44. Garlid KD, Jaburek M, Jezek P: The mechanism of proton transport mediated
by mitochondrial uncoupling proteins. FEBS Lett 438:10–14, 1998
45. Himms-Hagen J, Harper ME: Physiological role of UCP3 may be export of
fatty acids from mitochondria when fatty acid oxidation predominates: an
hypothesis. Exp Biol Med (Maywood) 226:78–84, 2001
MITOCHONDRIAL UNCOUPLING IN TYPE 1 DIABETES HEARTS
2932 DIABETES, VOL. 57, NOVEMBER 2008